Apogee Therapeutics, Inc. APGE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $6.28B.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s market capitalization?
- Apogee Therapeutics, Inc. (APGE) reported market capitalization of $6.28B in Q1 2026.
- How has Apogee Therapeutics, Inc.'s market capitalization changed year-over-year?
- Apogee Therapeutics, Inc.'s market capitalization increased by 189.3% year-over-year, from $2.17B to $6.28B.
- What is the long-term trend for Apogee Therapeutics, Inc.'s market capitalization?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s market capitalization has grown at a 96.1% compound annual growth rate (CAGR), from $1.34B to $5.16B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.